Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
Researchers seek to predict markers of the state of obesity, the risk of associated complications and the response to diet or bariatric surgery.
Read Full NewsNew findings from the EMBARK study highlight Elevidys' significant long-term benefits in slowing Duchenne muscular dystrophy progression in young patients.
A study of 614 brain donors revealed that individuals with stage III or IV CTE face the greatest risk of dementia.
FDA Approves First Dual-Agent Eye Drop for Near Vision Loss
1.
COVID Lockdowns Significantly Increasing Children's Vitamin D Deficiency?
2.
Adipocytes in the bone marrow offer early indicators of the development of multiple myeloma from MGUS.
3.
The need for more Latinx participants in Alzheimer's trials is urgent.
4.
Prostate cancer therapies: AI-based image analysis detects early organ damage
5.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
1.
Lu-177 Vipivotide in Prostate Cancer: A Breakthrough in Radioligand Therapy
2.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
3.
The Danger of Methemoglobinemia and How to Prevent It
4.
Unlocking the Potential of Talquetamab: A Revolutionary Approach to Cancer Treatment
5.
The Predictive Power of Targeted Radionuclide Therapy in Advanced Breast Cancer
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
2.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
3.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
5.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge